HealthEquity (NASDAQ:HQY) Releases Earnings Results, Beats Expectations By $0.11 EPS

HealthEquity (NASDAQ:HQY) released its quarterly earnings data on Wednesday. The company reported $1.01 earnings per share for the quarter, topping the consensus estimate of $0.90 by $0.11, FiscalAI reports. HealthEquity had a net margin of 14.86% and a return on equity of 12.95%. The business had revenue of $322.16 million for the quarter, compared to analyst estimates of $320.92 million. During the same quarter last year, the firm earned $0.78 EPS. HealthEquity’s quarterly revenue was up 7.2% compared to the same quarter last year. HealthEquity updated its FY 2026 guidance to 3.870-3.950 EPS.

HealthEquity Stock Down 3.0%

NASDAQ:HQY opened at $95.67 on Friday. The stock has a 50-day simple moving average of $96.41 and a 200 day simple moving average of $96.87. HealthEquity has a 52-week low of $74.07 and a 52-week high of $116.65. The company has a market cap of $8.24 billion, a PE ratio of 43.89, a PEG ratio of 1.42 and a beta of 0.18. The company has a debt-to-equity ratio of 0.47, a quick ratio of 4.23 and a current ratio of 4.23.

Analyst Upgrades and Downgrades

A number of equities analysts have recently weighed in on the stock. Citizens Jmp lifted their price target on shares of HealthEquity from $117.00 to $122.00 and gave the stock a “market outperform” rating in a research report on Thursday. Royal Bank Of Canada raised their price objective on HealthEquity from $109.00 to $110.00 and gave the stock an “outperform” rating in a research note on Wednesday, September 3rd. Jefferies Financial Group increased their price target on HealthEquity from $130.00 to $134.00 and gave the stock a “buy” rating in a report on Wednesday, September 3rd. Wall Street Zen cut HealthEquity from a “buy” rating to a “hold” rating in a report on Saturday, November 15th. Finally, JMP Securities set a $122.00 target price on HealthEquity in a research note on Thursday. One equities research analyst has rated the stock with a Strong Buy rating, twelve have assigned a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $120.07.

Insider Activity at HealthEquity

In other HealthEquity news, EVP Michael Henry Fiore sold 1,781 shares of the company’s stock in a transaction that occurred on Tuesday, October 7th. The stock was sold at an average price of $88.21, for a total transaction of $157,102.01. Following the completion of the transaction, the executive vice president owned 49,795 shares of the company’s stock, valued at $4,392,416.95. This represents a 3.45% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, EVP Delano Ladd sold 1,500 shares of HealthEquity stock in a transaction that occurred on Thursday, November 20th. The shares were sold at an average price of $104.56, for a total transaction of $156,840.00. Following the completion of the sale, the executive vice president owned 75,479 shares in the company, valued at $7,892,084.24. This trade represents a 1.95% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 10,781 shares of company stock worth $1,016,707 in the last 90 days. Company insiders own 1.50% of the company’s stock.

Hedge Funds Weigh In On HealthEquity

Several hedge funds have recently modified their holdings of the stock. Larson Financial Group LLC raised its holdings in HealthEquity by 24.4% during the third quarter. Larson Financial Group LLC now owns 628 shares of the company’s stock worth $60,000 after acquiring an additional 123 shares in the last quarter. iSAM Funds UK Ltd bought a new position in HealthEquity in the third quarter valued at approximately $117,000. Merit Financial Group LLC increased its position in shares of HealthEquity by 8.9% during the 3rd quarter. Merit Financial Group LLC now owns 2,112 shares of the company’s stock worth $200,000 after purchasing an additional 172 shares during the last quarter. Advisory Services Network LLC bought a new stake in shares of HealthEquity during the 3rd quarter worth approximately $207,000. Finally, Focus Partners Wealth acquired a new stake in shares of HealthEquity in the 3rd quarter valued at approximately $213,000. Institutional investors own 99.55% of the company’s stock.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.